PATENT CLAIM ANALYSIS

Application Number: 16008852
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["424", "191100"]

Abstract:
The invention is directed to a composition comprising one or more polypeptides or one or more nucleic acid sequences that can induce a protective immune response against  Plasmodium  species that infect humans. The invention also is directed to a method of using such compositions to induce a protective immune response against a  Plasmodium  parasite in a mammal.

Claim (Index 92):
The composition of  claim 89 , wherein the adenoviral vector requires complementation of a deficiency in the E1A region or the E1B region of the adenoviral genome for propagation and does not require complementation of any other deficiency of the adenoviral genome for propagation.

Metadata:
- Claim Count in Document: 64.0
- Percentile: 94.0
- Lexical Diversity: 1.63889
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14441988', '15492016', '15482991', '14992152', '14349421']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7252050731444966
- 35 USC 102 Novelty (BERT): 0.5318174411764507
- Combined Prediction Score: 0.7058663099476921
- Mean Citation Score: 313.774556
- Max Citation Score: 344.73837000000015
- Similarity Product: 297.48728020178686

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test